Regardless of tumor latencies, an indistinguishable tumor spectrum arose in irradiated smArf males and females (62% sarcomas, 38% lymphomas) similar to that observed in Arf-null mice [3]. The gene discussed is CDKN2A; the disease is neoplasm.